Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Radiation Biology|February 4, 2021
Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway frameworkVinita Chauhan, Ruth C Wilkins, Danielle Beaton, et al.Cell|May 2, 2017
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus MonkeysMalika Aid, Peter Abbink, Rafael A Larocca, et al.Vaccines|June 21, 2020
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored VaccinesCésar López-Camacho, Giuditta De Lorenzo, Jose Luis Slon-Campos, et al.Journal of Neurotrauma|March 10, 2017
A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord InjuryFemke Streijger, Michael A Skinnider, Jason C Rogalski, et al.Plos Pathogens|August 4, 2017
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Heather L Friberg, et al.Science Translational Medicine|December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeysPeter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.Nature Communications|June 24, 2018
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectorsCésar López-Camacho, Peter Abbink, Rafael A Larocca, et al.Nature|June 30, 2016
Vaccine protection against Zika virus from BrazilRafael A Larocca, Peter Abbink, Jean Pierre S Peron, et al.Journal of Medicinal Chemistry|February 16, 2007
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)Claudio F Sturino, Gary O'Neill, Nicolas Lachance, et al.Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.Pageof 10